Objective: Detecting the prevalence of human cytomegalovirus (CMV) coinfection in HIV-infected individuals attending a tertiary care hospital in Delhi by using 3 laboratory tests namely pp65 antigenemia assay, CMV DNA polymerase chain reaction (PCR), and immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA) for anti-CMV antibody. Design: HIV seropositive patients with CD4 count 100 cells/mm 3 were included as cases and HIV-negative healthy individuals as controls. Blood samples were collected from all participants and 3 tests were performed. Methods: pp65 antigenemia assay and IgM ELISA were performed by commercially available kits; PCR was performed by an in-house nested PCR method. Results: In all, 7.1%, 5.7%, and 2.9% were positive for pp65 antigenemia, CMV DNA, and IgM antibody against CMV, respectively. On the basis of pp65 and/or PCR positivity, it can be said that active CMV coinfection was present in 8.57% of the cases. Conclusion: In the postantiretroviral therapy (ART) era, CMV coinfection in HIV-infected patients has significantly declined.
Introduction
Human cytomegalovirus (CMV) is a ubiquitous virus with worldwide distribution, having a varied epidemiology and wide spectrum of manifestation. Although it rarely causes acute and significant disease in individuals with normal immune status, its importance in immunocompromised individuals cannot be overemphasized. It is one of the commonest viral opportunistic infections in HIV-infected population. Before the use of highly active antiretroviral therapy (HAART), approximately 20% to 40% of adults with AIDS developed CMV disease. Although HAART has substantially reduced the occurrence of CMV viremia and disease, it still poses a significant threat to patients having advanced immune impairment as in individuals with CD4 count 100 cells/mm 3 . 1 In India, with increased HIV care services and affordability of HAART in recent years, the natural history of HIV infection has significantly changed, with substantial decrease in opportunistic infections and deaths.
2 Although a few reports on CMV infection in Indian patients living with HIV/AIDS are available, 3 in this altered scenario, a re-evaluation of the trend of CMV coinfection in HIV-infected patients has assumed even a greater importance. In the current study, the objective was to detect the prevalence of CMV coinfection in HIV-infected individuals attending a tertiary care hospital in Delhi by using 3 laboratory tests namely pp65 antigenemia assay, CMV DNA polymerase chain reaction (PCR), and immunoglobulin M (IgM) enzymelinked immunosorbent assay (ELISA) for anti-CMV antibody.
Materials and Methods
The study was carried out in the Department of Microbiology, Maulana Azad Medical College, Delhi, India, during the period of October 2007 to April 2009. A total of 70 HIV seropositive patients enrolled with the antiretroviral therapy (ART) clinic Lok Nayak Hospital, New Delhi, with CD4 count 100 cells/mm 3 , were recruited in the study as cases. A total of 60 healthy individuals, all HIV-negative voluntary blood donors, at the blood bank in Lok Nayak hospital were taken as controls. Informed consent forms were taken from all the participants included in the study. A total of 8 mL of blood was collected from each patient-2 mL in plain vial and 6 mL in K 2 EDTA vial-and the following tests were performed with it.
pp65 Antigenemia Assay
It was performed using CINAkit (Argene, France). The CINAkit allows the indirect immunofluorescence detection of internal matrix phosphoprotein, pp65, of CMV in peripheral blood leukocytes. This method uses a monoclonal antibodies pool that recognizes the pp65 present in the nucleus of infected cells within 1 hour postinfection. The antibodies pool recognizes 2 epitopes of the protein expressed in the nucleus of peripheral blood CMV-infected polymorphonuclear and mononuclear cells, during blood dissemination. The test was performed following manufacturer's instruction. The slides were read under the fluorescence microscope using dry lens Â40.
Positive and negative slides obtained from Argene (prepared with CMV-infected and -uninfected human fibroblast cell line, respectively) were used to compare the slides made from sample and make the interpretations. Results were expressed as CMV-positive leukocytes per 2 Â 10 5 cells counted and even 1 positive leukocyte per 2 Â 10 5 has been considered positive and no positive leukocyte in the whole slide was considered negative.
Qualitative PCR
DNA extraction from both whole blood was performed by spincolumn method using SORPOclean Genomic DNA Extraction Module. An in-house PCR method was standardized in the course of the study and performed for all the samples. It was a nested PCR, the target region belonging to the major immediate early (MIE) gene. The primers were selected from the available literature 4, 5 and are mentioned below:
Outer set of primers:
Inner set of primers:
The reaction mixture consisted of 2 mmol/L MgCl 2 , 200 mmol/L of each dNTP, 20 pm each of the 2 primers, and 1.25 U of Taq DNA polymerase. The amplification reaction was performed in a thermal cycler (Eppendorf, Germany). After initial denaturation at 94 C, 40 cycles were performed, each cycle consisting of 30 seconds at 92 C, 30 seconds at 57 C 45 seconds at 72 C, and finally 5 minutes at 72 C. The initial cycling was followed by another round of 40 similar cycles.
Immunoglobulin M ELISA
Immunoglobulin M antibody was detected with EIAgen kit (Adaltis, Italy) and the procedure was performed using manufacturer's instructions. Per this instruction, a validation was carried out on the positive and negative controls to verify whether the performance of the assay was as qualified. The cutoff was calculated from the mean of control value.
The cases included in the study also underwent detailed ophthalmological examination that included visual acuity test, slit lamp examination for anterior segment, indirect ophthalmoscopy, and 90D examination for detailed fundoscopy.
Statistical analysis was performed using Pearson chi-square test and Fisher exact test.
Results
Among the patients in the study group, 48 (68.57 %) were males and 20 (28.57%) were females, while only 2 (2.86%) were eunuchs. The mean age of the study group was approximately 37 years. Majority of the patients presented with unexplained persistent fever for more than 1 month (42.85%), unexplained chronic diarrhea for more than 1 month (31.43%), moderate or severe weight loss (45.71%), recurrent respiratory illness (18.57%), and candidiasis (8.57%). Three cases had abnormal ophthalmological findings, of which 2 had findings pathognomonic of CMV retinitis.
Among the 70 cases, 5 (7.1%) were positive with pp65 assay while 65 (92.9%) were found negative. Four (5.7%) cases were positive for CMV DNA by PCR and 2 (2.9%) were positive for anti-CMV IgM antibody by ELISA. Among the 5 cases who showed positivity by pp65 assay, only 3 tested positive by PCR and only 2 of them were positive for anti-CMV antibody also ( Table 1) .
Of 60 controls, 4 were female, the rest male, the average age was approximately 33 years, and none showed positivity by pp65 assay or PCR, but 3 of them showed positivity for anti-CMV antibody by IgM ELISA.
Discussion
Although still CMV is a common viral opportunistic infection in HIV-infected individuals and gives rise to quite severe and serious manifestations, 6 in the present age of HAART, its incidence has come down drastically as compared to pre-HAART era. 7, 8 According to 1 study spanning 20 years and conducted by Kim et al, the incidence of a first episode of CMV disease decreased from a mean incidence of 40 cases per 1000 person-years during the pre-HAART era to 4 cases per 1000 person-years during the HAART era. Moreover, the 
Abbreviations: CMV, cytomegalovirus; ELISA, enzyme-linked immunosorbent assay; IgM, immunoglobulin M; PCR, polymerase chain reaction; þ, positive by the corresponding test; À, negative by the corresponding test.
occurrence of disease is clustered in the patient subgroup having CD4 count 9,10 <100 cells/mm 3 and this CD4 count is a significant covariate of development of CMV end-organ disease. 11 In the current study, all the patients who had active CMV infection as shown by positive pp65 antigenemia assay and/ or PCR had CD4 counts < 50 cells/mm 3 (P < .05) and among them only 1 was on HAART while the rest were HAART naive. The case that was on HAART was taking the treatment for 4 years but had a CD4 count of <100 cells/mm 3 persistently, so it can be considered a case of treatment failure (World Health Organization [WHO] definition). This case was positive for CMV by all 3 tests, that is pp65, PCR, and IgM ELISA, had the highest level of pp65 antigenemia (256 positive cells in 2 Â 10 5 leukocytes) in the study group, and had clinically diagnosed CMV retinitis in both eyes. Clinically diagnosed CMV retinitis was present in another patient who was also positive by pp65 antigenemia assay and PCR but negative by IgM ELISA. In fact, there was statistically significant difference (P < .05) between results obtained by IgM ELISA (2.9% positive) and results obtained by PCR (5.7% positive) and pp65 (7.1% positive), which can be explained by the patients severely immunosuppressed state of the patients and consequent lack of antibody production ability. 1 The pp65 assay and PCR used in the current study appeared to be highly specific as they yielded negative results in all the healthy controls. Cases with positive pp65 assay and/or positive PCR results showed signs and symptoms suggestive of CMV infection other than retinitis in varied proportion. Fever was present in 3 of the cases, diarrhea was present in 4, arthralgia/myalgia in 2, and anorexia was present in 2 of the cases though histopathological examination to conclusively establish CMV as the causative agent could not be undertaken. However, all these findings have been attributed to CMV infection in multiple studies on the basis of histopathological examination. [12] [13] [14] So, on the basis of pp65 and/or PCR positivity, it can definitely be said that active CMV coinfection was present in 8.57% of the cases in the current study and at least some of their symptoms were manifestations of that coinfection. Three diagnostic tests have been used in the current study as each of them has certain advantages and disadvantages over the others. While IgM ELISA is the least expensive and easiest to perform, it may not be very useful for diagnosis in immunocompromised patients, as there may be delay in antibody production in those cases or even sometimes absolute inability to mount antibody response that obviously reduces the sensitivity of the test. The pp65 assay, however, though sensitive and able to give a quantitative measure of viral load along with an approximate idea of risk of development of symptomatic disease, has the disadvantage of being labor-intensive, time-consuming, and is required to perform within hours of collection of blood samples. Cytomegalovirus DNA detection by PCR, especially when performed with nested primers to a single gene fragment, is a very sensitive method; but DNA can be detected in blood in the absence of disease and can be found even after successful resolution of disease in sytmptomatic patients. 1, 15 Further studies among HIV-positive individuals with larger sample size and more importantly with follow-up of cases at regular intervals are required not only to detect coinfection or existing disease but also to establish the utility of these diagnostic methods in predicting the development of CMV end-organ diseases and identifying the group of patients needing preemptive anti-CMV therapy to avert these diseases that often have life-threatening consequences.
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